Skip to Main Content

We have a new app!

Take the Access library with you wherever you go—easy access to books, videos, images, podcasts, personalized features, and more.

Download the Access App here: iOS and Android. Learn more here!


Fexinidazole is recommended by the World Health Organization as first-line therapy and is FDA-approved for treatment of early and advanced (CNS) West African disease.

Hidalgo J et al. Cureus. [PMID: 34513456]


Alternative therapies increasingly used to treat cutaneous leishmaniasis are miltefosine, which benefits from oral dosing and relatively little toxicity, and amphotericin B, which is widely available.

Machado PRL et al. Clin Infect Dis. [PMID: 32894278]


Artemisinin resistance is mediated by any of a series of mutations in the Plasmodium falciparum kelch (K13) gene; of great concern, these same mutations and evidence for delayed clearance after treatment with artemisinins were reported in East Africa in 2021.

Balikagala B et al. N Engl J Med. [PMID: 34551228]

Pop-up div Successfully Displayed

This div only appears when the trigger link is hovered over. Otherwise it is hidden from view.